Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04592783Completed
Randomised, open-label trial in hypertension (HTN) (2 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Composite Maternal Morbidity at 2 weeks. Started Oct 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04592783.